GF Fermentech

Innovative biotech company with distinct core technology based on fermentation, biotransformation, purification

Sejong, South Korea · Founded 2000 · $5.9M raised

Headquarters
Sejong
Employees
51–200
Founded
2000
Business Model
B2B
Total Funding
$5.9M
Last Round
$5.9M Corporate RoundMay 2025
Rounds
1

About

GF Fermentech, a subsidiary of HLB Genex, produces bioactive materials with core technologies based on strain development, fermentation, biotransformation, purification, and formulation. Over the past 20 years, the company has developed best-performing microbial strains and highly specialized extraction, purification, and formulation technologies to supply best-in-class bioactive ingredients including Vitamin K2 MK7, Nattokinase, Lactobionic acid, and Phytosphingosine for the nutraceutical and cosmeceutical markets. GF Fermentech also operates as a CDMO, offering contract manufacturing and scale-up from lab to commercial scale (up to 160KL fermentation capacity), and is expanding into synthetic biology for renewable and sustainable bio-products. The company holds GMP and LMO certifications and has been selected for South Korea's Ministry of SMEs and Startups Jump-Up Program.

Summary

GF Fermentech is a Biotech company based in Sejong, South Korea, founded in 2000. It has raised $5.9M in total across 1 round, most recently a $5.9M Corporate Round round in May 2025. Investors include Premier Inc. and Innopolis Partners.

Tech & App Stack

1 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMay 2025
$5.9M

Investors

Similar Companies